ReviewJournal of neuro-oncology2004
Molecular pathogenesis of astrocytic tumours.
Review in Journal of neuro-oncology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells.Cell death & disease · 2018Pooled it
- Screening key genes and pathways in glioma based on gene set enrichment analysis and meta-analysis.Journal of molecular neuroscience : MN · 2013Pooled it
- Neurocognitive function and health-related quality of life among glioblastoma patients: A prospective study.Journal of public health in Africa · 2025Article
- The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response.Frontiers in oncology · 2021Review
- Article
- Subventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlation.Scientific reports · 2017Article
- Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors.Advanced biomedical research · 2017Article
- Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Critical reviews in immunology · 2014Review
- Effects of single or combined treatments with radiation and chemotherapy on survival and danger signals expression in glioblastoma cell lines.BioMed research international · 2014Article
- Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies.Biochimica et biophysica acta · 2013Review
- Tumor prognostic factors and the challenge of developing predictive factors.Current oncology reports · 2013Article
- Article
- Cryo-image analysis of tumor cell migration, invasion, and dispersal in a mouse xenograft model of human glioblastoma multiforme.Molecular imaging and biology · 2012Article
- Targeted tissue proteomic analysis of human astrocytomas.Journal of proteome research · 2012Article
- MAPK pathway activation in pilocytic astrocytoma.Cellular and molecular life sciences : CMLS · 2012Review
- The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.Cellular and molecular neurobiology · 2012Article
- Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models.BMB reports · 2011Review
- Protein kinase a in cancer.Cancers · 2011Article
- Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.Brain pathology (Zurich, Switzerland) · 2010Article
- A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu.Neoplasia (New York, N.Y.) · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our current knowledge of the molecular pathogenesis of the diffuse adult astrocytic tumours is vast if compared to 20 years ago, yet we are far from understanding the details of this process at the molecular level and using such an understanding to logically and specifically treat patients' tumours. In other astrocytic tumours we have little or no knowledge of the molecular processes. This article will attempt to summarise the histological classification criteria and genetic data for all the astrocytic tumours. The current World Health Organisation classification lists six entities, some with subgroups. Common problems associated with the diagnosis of these tumours are outlined. While the molecular findings are not as yet used clinically, we are approaching a time when the histological investigation will have to be supplemented with molecular data to ensure the best choice of treatment for the patient and as an accurate indicator of prognosis.
Indexed as
Identifiers
15674475What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.